Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The person must be male and older than 18 years of age.
- The person must have a history of localised prostate cancer (a specific type called adenocarcinoma) that was previously treated with the aim of curing it, and the cancer must now be showing signs of returning based on a blood marker called PSA, while still being hormone-sensitive.
- The previous treatment must have included one or more of the following: surgical removal of the prostate (radical prostatectomy), surgical removal of the prostate followed by additional therapy, or radiation therapy and/or hormone-blocking therapy.
- The person's PSA levels must meet specific thresholds depending on which treatment was received: after surgical removal of the prostate, the PSA must be 0.2 ng/mL or higher on two separate measurements, and fall between 0.2 and 2 ng/mL overall, with testing done at least 6 weeks after surgery; after radiation therapy as the primary treatment, the PSA must be at least 2 ng/mL above the lowest level it reached after treatment, and fall within the range of 2 to 4 ng/mL.
Who may not be able to join:
- People who have any medical condition or situation that the trial doctor believes could affect the reliability of the study data or make it difficult to complete the study requirements (confirm with trial site).
- People who are currently receiving, or have recently received within the last 3 months, hormone-blocking therapy — this includes surgical removal of the testicles, ongoing or intermittent hormone-suppressing injections or implants, or anti-androgen medications used alone or in combination with hormone-suppressing treatments.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Matthias Eiber, MD, Technical University of Munich
Phone: +49 89 4140 0
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient-level detection rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.